JP2024543135A5 - - Google Patents
Info
- Publication number
- JP2024543135A5 JP2024543135A5 JP2024531057A JP2024531057A JP2024543135A5 JP 2024543135 A5 JP2024543135 A5 JP 2024543135A5 JP 2024531057 A JP2024531057 A JP 2024531057A JP 2024531057 A JP2024531057 A JP 2024531057A JP 2024543135 A5 JP2024543135 A5 JP 2024543135A5
- Authority
- JP
- Japan
- Prior art keywords
- dioxopyrrolidine
- propanamide
- methyl
- phenyl
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PLP.439639 | 2021-11-24 | ||
| PL439639A PL244897B1 (pl) | 2021-11-24 | 2021-11-24 | Deuterowane funkcjonalizowane pochodne α-alaniny, zwłaszcza do leczenia chorób neurologicznych |
| PCT/PL2022/050083 WO2023096512A1 (en) | 2021-11-24 | 2022-11-24 | DEUTERATED FUNCTIONALIZED DERIVATIVES OF α-ALANINE, IN PARTICULAR FOR THE TREATMENT OF NEUROLOGICAL DISEASES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543135A JP2024543135A (ja) | 2024-11-19 |
| JP2024543135A5 true JP2024543135A5 (https=) | 2025-12-01 |
Family
ID=84980841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531057A Pending JP2024543135A (ja) | 2021-11-24 | 2022-11-24 | 特に神経疾患を処置するためのα－アラニンの重水素化官能化誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250042848A1 (https=) |
| EP (1) | EP4436954A1 (https=) |
| JP (1) | JP2024543135A (https=) |
| KR (1) | KR20240110038A (https=) |
| CN (1) | CN118302410A (https=) |
| AU (1) | AU2022395821A1 (https=) |
| CA (1) | CA3236670A1 (https=) |
| MX (1) | MX2024005981A (https=) |
| PL (1) | PL244897B1 (https=) |
| WO (1) | WO2023096512A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025085878A1 (en) * | 2023-10-20 | 2025-04-24 | Altay Therapeutics, Inc. | N-phenyl-3-(2,5-dioxopyrrolidin-1-yl)propanamide derivatives and similar compounds as dux4 inhibitors for the treatment of e.g. neuromuscular disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL244071B1 (pl) * | 2019-01-07 | 2023-11-27 | Univ Jagiellonski | Pochodne (2,5-dioksopirolidyn-1-ylo)(fenylo)-acetamidu i ich zastosowanie do leczenia chorób o podłożu neurologicznym |
| PL240297B1 (pl) * | 2019-04-16 | 2022-03-14 | Univ Jagiellonski | Modyfikowane pochodne aminokwasowe do leczenia chorób o podłożu neurologicznym oraz wybranych zaburzeń psychiatrycznych |
-
2021
- 2021-11-24 PL PL439639A patent/PL244897B1/pl unknown
-
2022
- 2022-11-24 EP EP22843893.3A patent/EP4436954A1/en active Pending
- 2022-11-24 AU AU2022395821A patent/AU2022395821A1/en active Pending
- 2022-11-24 MX MX2024005981A patent/MX2024005981A/es unknown
- 2022-11-24 WO PCT/PL2022/050083 patent/WO2023096512A1/en not_active Ceased
- 2022-11-24 US US18/711,775 patent/US20250042848A1/en active Pending
- 2022-11-24 CA CA3236670A patent/CA3236670A1/en active Pending
- 2022-11-24 JP JP2024531057A patent/JP2024543135A/ja active Pending
- 2022-11-24 CN CN202280077941.8A patent/CN118302410A/zh active Pending
- 2022-11-24 KR KR1020247020140A patent/KR20240110038A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022171666A5 (https=) | ||
| JP2022540935A5 (https=) | ||
| JP2013139446A5 (https=) | ||
| JP2019038829A5 (https=) | ||
| JP2017511339A5 (https=) | ||
| JP2025510414A5 (https=) | ||
| JP2024504252A5 (https=) | ||
| JP2022516575A (ja) | ケタミン誘導体およびその組成物 | |
| JP2019524822A5 (https=) | ||
| JP2024543135A5 (https=) | ||
| JP2021513975A5 (https=) | ||
| EA016687B8 (ru) | Производные циклопропиламида | |
| JP2022515293A5 (https=) | ||
| JP2022153638A5 (https=) | ||
| JP4040089B2 (ja) | ２−（４−置換）−ベンジルアミノ−２−メチル−プロパンアミド誘導体 | |
| FI3956310T3 (fi) | Modifioituja aminohappojohdannaisia neurologisten sairauksien ja valittujen psykiatristen häiriöiden hoitamiseksi | |
| JP2019516739A5 (https=) | ||
| JP2019530674A5 (https=) | ||
| JP2010522711A5 (https=) | ||
| JP2024529728A5 (https=) | ||
| JP2019537624A5 (https=) | ||
| JP2023011735A5 (https=) | ||
| JP2016537432A5 (https=) | ||
| JP5774694B2 (ja) | フェニルカルバメート化合物およびこれを含む筋肉弛緩剤 | |
| JP2009500420A5 (https=) |